Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

1. Construction of a treatment response prediction model for multiple myeloma based on multi-omics and machine learning.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
   Article
2. Inositol 1,3,4,5-tetrakisphosphate: a remarkable second messenger in platelet signaling.Research and practice in thrombosis and haemostasis · 2024
   Article
3. Tumor suppressor let-7 acts as a key regulator for pluripotency gene expression in Muse cells.Cellular and molecular life sciences : CMLS · 2024
   Article
4. Targeting STAT3 Enzyme for Cancer Treatment.Mini reviews in medicinal chemistry · 2024
   Review
5. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.Scientific reports · 2023
   Article
6. The journey of neutropoiesis: how complex landscapes in bone marrow guide continuous neutrophil lineage determination.Blood · 2022
   Article
7. Dectin-1 Signaling Update: New Perspectives for Trained Immunity.Frontiers in immunology · 2022
   Review
8. Investigating increased hematopoietic stem cell fitness in a novel mouse model.Small GTPases · 2022
   Article
9. Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia.Blood · 2021
   Article
10. Molecular medicine reports · 2021
    Article
11. A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency.Haematologica · 2021
    Article
12. Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.Frontiers in medicine · 2021
    Article
13. Updates on new monogenic inborn errors of immunity.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2020
    Article
14. Regulation of Hematopoietic Stem Cell Fate and Malignancy.International journal of molecular sciences · 2020
    Review
15. Severe combined immunodeficiency caused by inositol-trisphosphate 3-kinase B (ITPKB) deficiency.The Journal of allergy and clinical immunology · 2020
    Article
16. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.Cellular signalling · 2020
    Article
17. SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
18. The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response.Cancers · 2019
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as